Analyst Reco. RegenETP, Inc.

Equities

Delayed OTC Markets Other stock markets 07:15:12 26/04/2024 pm IST			5-day change	1st Jan Change
0.0699 ^USD	0.00%		+244.33%	+38.97%

22/03	North American Morning Briefing : Stocks Struggle After New Records	DJ
26/02	PolarityTE Screens First Subject in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers	CI

Northland Securities Adjusts Price Target on PolarityTE to $1 From $1.25, Maintains Outperform Rating	28/22/28	MT
Cantor Fitzgerald Downgrades PolarityTE to Neutral From Overweight, Adjusts Price Target to $1 From $2.50	31/22/31	MT

No results for this search